Cutaneous T cell lymphoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or S ézary Syndrome
Conditions: Mycosis Fungoides; Mycosis Fungoides/Sezary Syndrome; Sezary Syndrome; Sézary; Advanced Mycosis Fungoides Interventions: Drug: Gemcitabine; Drug: Pembrolizumab Sponsor: Memorial Sloan Kettering Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2021 Category: Research Source Type: clinical trials
